medical
25 articles tagged
Lifeward's Medicare reimbursement wins mask execution risks: $25.6M 2024 revenue missed guidance, and payer approvals haven't converted to profitable device volume.
Lifeward (formerly ReWalk Robotics) has secured Medicare reimbursement and commercial insurer approvals for its exoskeleton platform, but faces execution challenges with a $9M market cap and missed revenue targets.
Ekso Bionics secures Medicare reimbursement for personal exoskeletons but faces execution challenges converting regulatory advantage into sustainable unit economics at $18M revenue.
Fourier Intelligence's humanoid pivot masks a bifurcated company: a verified $234.9M clinical robotics business versus unproven GR-1/GR-3 deployments amid a 42-point Mosaic Score decline.
Fourier Intelligence leverages its rehabilitation robotics expertise to enter the humanoid market with the GR-3, but faces competition from better-funded rivals in a crowded field.
Rainbow Robotics' Samsung partnership masks deeper challenges: massive EBITDA burn, 132 employees pursuing seven hardware platforms simultaneously, and zero named customer deployments.
Cyberdyne's HAL exoskeleton platform has built a defensible clinical position over 20 years but faces profitability pressure. With narrowing losses and early Americas traction, the company signals a shift toward commercial discipline in 2025.
Cyberdyne's Americas growth masks stagnant core device revenue and unresolved U.S. reimbursement challenges despite two decades of operating losses.
Arrive AI completes first live clinical deployment of autonomous biospecimen transfer at Hancock Regional Hospital, addressing secure handoff gaps in hospital logistics.
Aethon's 20-year hospital deployment track record reveals a structurally defensible moat built on building integration, federal procurement access, and Oracle partnership—not commodity AMR competition.